GxPinnacle Logo
Skip to content

What Do Inspectors Check for Pharmacovigilance Literature Case Processing?

Literature case processing is the step where pharmacovigilance teams convert a publication containing a suspected adverse reaction into an Individual Case Safety Report (ICSR). Regulators expect organisations to validate minimum case criteria, determine day zero correctly, document medical review, and ensure cases are entered and reported through safety systems within regulatory timelines.

For: Founders, CEOs & MDs·PV Leads·QA/Compliance·Scientists tasked with documentation

Alignment: Global pharmacovigilance principles (ICH-aligned) and inspection practices

Most useful when: Preparing for inspection, setting up a process, or closing a documentation gap

Key points

  • Publications identified during literature surveillance must be processed as Individual Case Safety Reports (ICSRs).
  • Case validity must be assessed using minimum criteria: identifiable patient, identifiable reporter, suspect medicinal product, and suspected adverse reaction.
  • Day zero must be determined consistently and documented to ensure correct regulatory reporting timelines.
  • Literature cases must be traceable from publication identification through screening, case processing, and regulatory submission.
  • Medical review and coding should be documented according to pharmacovigilance procedures.
  • Safety databases and case management systems should demonstrate accurate and timely entry of literature cases.

What inspectors expect

Each point below should be supported by controlled documents and traceable records.

  • Literature publications containing suspected adverse reactions must be evaluated for minimum case validity.
  • Valid literature cases must be processed as ICSRs and entered into safety systems.
  • Day zero must be determined consistently to ensure correct reporting timelines.
  • Literature case processing must be traceable from screening records to case database entries.
  • Medical review and coding decisions must be documented.

Summary

Publications identified during literature surveillance that meet minimum case criteria must be processed as Individual Case Safety Reports (ICSRs) with documented validation, day-zero determination, and traceability to regulatory reporting.

Common questions

These are the questions this page is designed to answer directly.

  • How should literature cases be processed in pharmacovigilance?
  • How are ICSRs created from medical literature?
  • What do inspectors expect for literature case processing?
  • How is day zero determined for literature cases?
  • What documentation is required for literature ICSR processing?
  • How do literature cases enter the safety database?
  • What evidence do inspectors request for literature case handling?
  • How should literature publications be assessed for minimum case criteria?
  • What are common inspection findings for literature case processing?
  • How do inspectors verify traceability from literature hit to ICSR reporting?

Evidence objects inspectors expect

Literature Case Processing SOP

  • Defined process for converting literature hits into ICSRs
  • Minimum case validity criteria
  • Case intake workflow and responsibilities
  • Day zero determination rules
  • Medical review and coding procedures
  • Reporting obligations and timelines

Case Intake and Validation Documentation

  • Case intake forms capturing literature source
  • Documentation confirming minimum case criteria
  • Record of reviewer performing case validation
  • Evidence linking literature publication to case record

Safety Database Records

  • ICSR entry in safety database referencing literature source
  • Case identifiers linking literature publication to database entry
  • Documentation of coding (e.g., MedDRA terms)
  • Evidence of medical review or clinical assessment

Day Zero Determination Evidence

  • Documented determination of the date the organisation became aware of a valid case
  • Traceability from literature screening decision to case processing timeline
  • Evidence supporting reporting timelines

Regulatory Reporting Records

  • Evidence of expedited reporting where applicable
  • Submission records to EudraVigilance or other safety reporting systems
  • Internal tracking of regulatory reporting timelines

Regulatory Basis (Primary Sources)

  • GVP Module VI – literature reports must be assessed and processed as ICSRs where valid
  • ICH E2D – requirements for post-marketing literature case reporting
  • EMA Medical Literature Monitoring guidance – case identification and reporting expectations
  • MHRA pharmacovigilance guidance – obligations for literature case reporting

Typical Inspection Questions (What Inspectors Ask)

  • How do you determine whether a literature publication contains a valid ICSR?
  • Show me a literature case and trace it through to your safety database.
  • How do you determine day zero for literature cases?
  • What evidence shows the case was reported within regulatory timelines?
  • How are literature cases medically reviewed before submission?

Failure patterns

Incorrect determination of minimum case criteria: publications containing potential ICSRs are excluded due to misunderstanding of validity requirements.

Incorrect day zero determination leading to reporting delays.

Weak traceability between literature screening logs and safety database entries.

Delayed entry of literature cases into the safety database.

Incomplete documentation of case validation and medical review.

What good looks like

  • Literature cases are validated consistently against defined minimum case criteria.
  • Day zero determination is documented and consistently applied.
  • Traceability exists from literature hit to screening decision to ICSR database entry.
  • Medical review and coding decisions are clearly documented.
  • Cases are entered into safety systems and reported within regulatory timelines.

Operationalisation

  • Define literature case validation criteria aligned with regulatory minimum case requirements.
  • Ensure literature hits that meet case criteria are escalated immediately for case processing.
  • Document day zero determination rules and ensure they are applied consistently.
  • Maintain traceability between literature screening records and safety database entries.
  • Perform medical review and coding according to established pharmacovigilance procedures.
  • Track regulatory reporting timelines for literature cases and document submissions.

Need regulatory documentation today?

Save time and reduce inspection risk with structured, pre-built process-ready documentation.
Created by industry professionals, adaptable to your organisation.

Related pre-built documentation inside the app

Get AccessLog In

FAQ

When does a literature publication become a reportable ICSR?

A literature publication becomes a reportable ICSR when it contains the minimum case information required: identifiable patient, identifiable reporter, suspect medicinal product, and suspected adverse reaction.

How is day zero determined for literature cases?

Day zero is typically the date the organisation becomes aware that a publication contains a valid ICSR. This date triggers regulatory reporting timelines.

Do literature cases need to be entered into the safety database?

Yes. Valid literature cases must be entered into the pharmacovigilance safety database and processed according to ICSR reporting requirements.

Do inspectors review literature cases during inspections?

Yes. Inspectors often select literature publications and request evidence showing how they were assessed, processed as cases, and reported where applicable.

What documentation is expected for literature case processing?

Inspectors typically expect documentation of case validity assessment, safety database entries, medical review records, and regulatory reporting evidence.

Sources

Primary guidance used to inform this map. This page is a structured interpretation layer; always validate against the original source documents.

European Medicines Agency (EMA)

  • Guideline on good pharmacovigilance practices (GVP) – Module VI
    View source
  • Medical literature monitoring
    View source

International Council for Harmonisation (ICH)

  • Post-Approval Safety Data Management: Definitions and Standards for Expedited Reporting (E2D)
    View source